ReviewACS nano2025
Voices of Nanomedicine: Blueprint Guidelines for Collaboration in Addressing Global Unmet Medical Needs.
Abstract readReview
In one paragraph
Review in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial intelligence driven protein design and sustainable nanomedicine for advanced theranostics.Bioactive materials · 2026Review
- Enhancing the Safety of Nanoparticles in Medicine: Highlights of Progress and Critical Objectives.International journal of nanomedicine · 2026Review
- Nanotechnology strategies for endometrium health: Are we on the right track?Bioactive materials · 2025Review
- Regulating nanomedicines: challenges, opportunities, and the path forward.Nanomedicine (London, England) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Rajendra PrasadSchool of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh 221005, India.
Arnab GhoshDepartment of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Bombay, Powai, Mumbai 400076, India.ORCID 0000-0001-7767-1150
Vinay PatelDepartment of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Bombay, Powai, Mumbai 400076, India.ORCID 0000-0001-7870-6677
Berney PengDepartment of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, California 90095, United States.
Bárbara B MendesNOVA Medical School|Faculdade de Ciências Médicas, NMS|FCM, Universidade NOVA de Lisboa, Lisbon 1169-056, Portugal.ORCID 0000-0001-8630-1119
Eaint Honey Aung WinDepartment of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, California 90095, United States.
Lucia Gemma DeloguDepartment of Biological Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, UAE.
Joyce Y WongDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.ORCID 0000-0002-3526-6381
Kristin J PischelDepartment of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, California 90095, United States.ORCID 0009-0003-4179-1339
Jayesh R BellareDepartment of Chemical Engineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.ORCID 0000-0002-6792-8327
Amnon Bar-ShirDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0003-1431-0221
Avnesh S ThakorInterventional Radiology Innovation at Stanford (IRIS), Department of Radiology, Stanford University, Palo Alto, California 94304, United States.ORCID 0000-0001-7395-0515
Wolfgang J ParakFachbereich Physik, Universität Hamburg, 22607 Hamburg, Germany.ORCID 0000-0003-1672-6650
Zaver M BhujwallaDivision of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.
Yu Shrike ZhangDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital Harvard Medical School, Cambridge, Massachusetts 02139, United States.
Nagavendra KommineniCenter for Biomedical Research, Population Council, New York, New York 10065, United States.
Vince M RotelloDepartment of Chemistry, University of Massachusetts, Boston, Massachusetts 01003, United States.ORCID 0000-0002-5184-5439
Weibo CaiDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin 53707, United States.ORCID 0000-0003-4641-0833
Twan LammersDepartment of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Faculty of Medicine, RWTH Aachen University, Aachen 52074, Germany.ORCID 0000-0002-1090-6805
Teri W OdomDepartment of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, United States.ORCID 0000-0002-8490-292X
Govindarajan PadmanabanDepartment of Biochemistry, Indian Institute of Science, Bengaluru 560 012, Karnataka India.
Dan PeerLaboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0001-8238-0673
Jonathan F LovellDepartment of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York 14260, United States.ORCID 0000-0002-9052-884X
Rohit SrivastavaDepartment of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Bombay, Powai, Mumbai 400076, India.ORCID 0000-0002-3937-5139
Robert LangerKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02115, United States.ORCID 0000-0003-4255-0492
João CondeNOVA Medical School|Faculdade de Ciências Médicas, NMS|FCM, Universidade NOVA de Lisboa, Lisbon 1169-056, Portugal.ORCID 0000-0001-8422-6792
Funding
UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6MUCLA Tumor Immunology Training ProgramT32CA009120 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Steven M. Dubinett, MICHAEL A TEITELL · 1985 to 2026
$10.3MNCI NIH HHS P30 CA014520NCI NIH HHS T32 CA009120
Abstract
The "
Indexed as
NanomedicineCooperative BehaviorCOVID-19COVID-19 VaccinesGlobal HealthHumansSARS-CoV-2COVID-19 Vaccineshealthcarelaboratory researchnanomedicine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.